A new Mount Sinai-led study has added to the growing evidence that long COVID may be driven, at least in part, by autoimmunity, offering a fresh line of inquiry for clinicians and researchers trying to understand why some patients continue to experience symptoms long after the initial infection has passed. The findings were reported on May 28, 2026 and described as showing that the body’s immune system attacks its own tissues in people with long COVID symptoms.
What the researchers reported
The study, published in the journal Cell Reports, examined the biological basis of persistent symptoms after COVID-19 and found evidence pointing to autoimmunity as a contributing factor. According to the report, the research team demonstrated that autoimmunity is responsible for long COVID symptoms. The work was led by Mount Sinai researchers and focuses on why ongoing illness can affect patients even after the acute phase of infection has ended. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
Long COVID remains a complex condition, and the new findings do not close the case on its causes. But they do strengthen the view that lingering symptoms may not be explained by one mechanism alone. Instead, immune dysregulation, including autoimmune activity, may be one of the key pathways involved. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
Why the result matters for patients
For patients, the importance of the study lies in the possibility that a better understanding of the immune mechanisms behind long COVID could eventually lead to more targeted treatments. If autoimmune processes are confirmed as a major driver in at least some cases, that could help doctors identify subgroups of patients who may benefit from different approaches to care. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
The research also highlights how long COVID continues to challenge routine clinical management. Symptoms can be broad and persistent, and the condition has remained difficult to define with a single explanation. Studies like this one are helping to narrow the field by identifying biological signals that may be useful in future diagnosis and treatment strategies. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
A wider research effort on persistent post-viral illness
Mount Sinai’s findings arrive as researchers continue to investigate the long-term effects of COVID-19 and the immune responses that may follow infection. While further studies will be needed to confirm how widely these results apply, the new report adds momentum to efforts aimed at explaining why some people recover quickly while others develop prolonged symptoms. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
For now, the study offers an important clue rather than a final answer. But in a field where patients and clinicians have often had more questions than evidence, any credible step toward explaining long COVID is likely to be closely watched. ([news-medical.net](https://www.news-medical.net/news/20260528/Mount-Sinai-study-links-long-COVID-symptoms-to-autoimmunity.aspx?utm_source=openai))
